<DOC>
	<DOCNO>NCT01828957</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety single intratracheal administration Pneumostem® treatment Bronchopulmonary Dysplasia ( BPD ) high-risk premature infant compare Pneumostem-treated group control group .</brief_summary>
	<brief_title>Efficacy Safety Evaluation Pneumostem® Versus Control Group Treatment BPD Premature Infants</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<criteria>Age : 5 14 day since birth Fetal gestational age : ≥23 week &lt; 29 week Birth weight : ≥500g ≤1250g Premature infant equal le 2 week age receive ventilator therapy rate &gt; 12 breath/min &gt; 25 % oxygen Patient whose ventilator set change show aggravation illness within 24 hour prior study enrollment Patient write consent form sign legal representative parent upon explanation clinical trial Patient concurrent cyanotic acyanotic congenital heart disease , except patent ductus arteriosus Patient concurrent severe lung malformation ( i.e . Pulmonary hypoplasia , congenital diaphragmatic hernia , congenital cystic lung disease ) Patient concurrent severe lung malformation chromosome anomaly ( i.e . Edward syndrome , Patau syndrome , Down syndrome , etc ) severe congenital malformation ( Hydrocephalus , Encephalocele , etc ) Patient concurrent severe congenital infection ( i.e . Herpes , Toxoplasmosis , Rubella , Syphilis , AIDS , etc ) Patient withCRP &gt; 30 mg/dL ; Severe sepsis shock Patient schedule expect undergo surgical procedure 72 hour prior to/following administration study drug Patient administer surfactant within 24 hour prior administration study drug Patient severe intracranial hemorrhage ≥ grade 3 4 Patient active pulmonary hemorrhage active air leak syndrome time screen Patient history participate clinical study Patient allergic Gentamicin Patient consider inappropriate participate study investigator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Human Umbilical Cord Blood Derived Mesenchymal Stem Cells</keyword>
	<keyword>Bronchopulmonary dysplasia</keyword>
	<keyword>Premature infant</keyword>
</DOC>